Advertisement
A standardized set of outcome measures

Standard Outcome Measures Developed for Pediatric Facial Palsy

0
Standard measures allow for recording outcomes of facial palsy treatments among pediatric patients
Physicians are aware of patients' difficulty with affording medical care and consider out-of-pocket costs in their decision making

Doctors Aware of Patient Difficulties Affording Medical Care

0
Three-quarters of doctors surveyed say they consider out-of-pocket costs when making clinical decisions
Health professionals are generally supportive of medicinal cannabis use but report a lack of knowledge about its use

Health Professionals Supportive of Medicinal Cannabis

0
However, across medicine, pharmacy, and nursing, providers need more information
In 2018

CDC: Uninsurance Levels Did Not Change Significantly in 2018

0
Uninsurance increased among adults aged 45 to 64 years; increase seen in high-deductible health plans
Men and women with type 2 diabetes have an increased risk for overall cancer and some site-specific cancers

Risk for Cancer Increased in Men, Women With T2DM

0
Standardized incidence ratio highest for prostate cancer for men, nasopharynx cancer for women
The American Cancer Society has set a goal of a 40 percent reduction in overall cancer mortality by 2035

ACS Sets Goal to Cut Cancer Mortality 40 Percent by 2035

0
Goal based on decrease in overall cancer death rates at pace seen among college graduates
In 2018

2018 Saw More Employed Physicians Than Self-Employed

0
Proportion of physicians working in practices wholly owned by physicians dropped to 54 percent in 2018
In 2015 to 2016

In 2015 to 2016, 45.8 Percent of U.S. Population Used Rx Drugs

0
Prescription drug use increased with age, reaching 85.0 percent for those aged 60 years and older
In response to public demands for action to control drug costs

Prices Will Soon Be Included in TV Drug Ads

0
Regulations will require companies to disclose prices of meds costing more than $35 for a month's supply
The average price for single-source brand-name drugs is higher in the United States than in other countries

External Reference Pricing Could Cut Drug Costs in U.S.

0
Prices averaged 3.2 to 4.1 times higher in U.S.; differential varied from 1.3 to 70.1 for individual drugs